Per ulteriori informazioni selezionare i riferimenti di interesse.
Haplotype analysis in Icelandic and Finnish BRCA2 999del5 breast cancer families
EUROPEAN JOURNAL OF HUMAN GENETICS
High collagenase-1 expression correlates with a favourable chemoimmunotherapy response in human metastatic melanoma
MELANOMA RESEARCH
Risk of cancer in BRCA1 and BRCA2 mutation-positive and -negative breast cancer families (Finland)
CANCER CAUSES & CONTROL
A prospective study on women with a history of breast cancer and with or without estrogen replacement therapy
MATURITAS
Survival of breast cancer patients in BRCA1, BRCA2, and non-BRCA1/2 breastcancer families: A relative survival analysis from Finland
INTERNATIONAL JOURNAL OF CANCER
Feasibility of prolonged use of interferon-alpha in metastatic kidney carcinoma - A phase II study
CANCER
Prospective study on gynaecological effects of two antioestrogens tamoxifen and toremifene in postmenopausal women
BRITISH JOURNAL OF CANCER
Analysis of G(1)/S checkpoint regulators in metastatic melanoma
GENES CHROMOSOMES & CANCER
Prognostic value of beta 1 integrin expression in metastatic melanoma
MELANOMA RESEARCH
Familial breast cancer in southern Finland: how prevalent are breast cancer families and can we trust the family history reported by patients?
EUROPEAN JOURNAL OF CANCER
Interferon-alpha and 13-cis-retinoic acid as maintenance therapy after high-dose combination chemotherapy with growth factor support for small cell lung cancer - a feasibility study
ANTI-CANCER DRUGS
Tumor doubling times in metastatic malignant melanoma of the uvea - Tumor progression before and after treatment
OPHTHALMOLOGY
Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Regimens with or without interferon-alpha as treatment for metastatic melanoma and renal cell carcinoma: An overview of randomized trials
JOURNAL OF IMMUNOTHERAPY
Concomitant chemotherapy and IFN-alpha for small cell lung cancer: A randomized multicenter phase III study
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
Prognostic value of tumour vascularity in primary melanoma
MELANOMA RESEARCH
Prognostic value of tumour vascularity in metastatic melanoma and association of blood vessel density with vascular endothelial growth factor expression
MELANOMA RESEARCH
Prospective randomized trial of interferon alfa-2a plus vinblastine versusvinblastine alone in patients with advanced renal cell cancer
JOURNAL OF CLINICAL ONCOLOGY
Familial breast cancer in Southern Finland
DISEASE MARKERS
Meta-analysis of trials comparing toremifene with tamoxifen and factors predicting outcome of antiestrogen therapy in postmenopausal women with breast cancer
BREAST CANCER RESEARCH AND TREATMENT
MIB-1 immunoreactivity correlates with blood vessel density and survival in disseminated malignant melanoma
ONCOLOGY
Screening for metastatic malignant melanoma of the uvea revisited
CANCER
PROGNOSTIC VALUE OF BIOMARKERS IN MALIGNANT-MELANOMA
Melanoma research
THE TREATMENT OF METASTATIC UVEAL MELANOMA
European journal of cancer
RANDOMIZED TRIAL OF IRINOTECAN PLUS SUPPORTIVE CARE VERSUS SUPPORTIVECARE ALONE AFTER FLUOROURACIL FAILURE FOR PATIENTS WITH METASTATIC COLORECTAL-CANCER
Lancet
TUMOR-INFILTRATING LYMPHOCYTES IN PATIENTS WITH METASTATIC MELANOMA RECEIVING CHEMOIMMUNOTHERAPY
Journal of immunotherapy
ORAL SOURCES OF SEPTICEMIA IN PATIENTS WITH MALIGNANCIES
Oral Oncology
5-YEAR FOLLOW-UP-STUDY OF SALIVA, MUTANS STREPTOCOCCI, LACTOBACILLI AND YEAST COUNTS IN LYMPHOMA PATIENTS
Oral Oncology
INTERFERON MAINTENANCE THERAPY FOR SMALL-CELL LUNG-CANCER - IMPROVEMENT IN LONG-TERM SURVIVAL
Journal of interferon & cytokine research
5-YEAR FOLLOW-UP OF SALIVA IN PATIENTS TREATED FOR LYMPHOMAS
Oral surgery, oral medicine, oral pathology, oral radiology and endodontics
LOW PROPORTION OF BRCA1 AND BRCA2 MUTATIONS IN FINNISH BREAST-CANCER FAMILIES - EVIDENCE FOR ADDITIONAL SUSCEPTIBILITY GENES
Human molecular genetics
DNA FLOW-CYTOMETRY AND THE OUTCOME OF CHEMOIMMUNOTHERAPY IN METASTATIC MELANOMA
Melanoma research
CAN THE CD4+ CD8+ RATIO PREDICT THE OUTCOME OF INTERFERON-ALPHA THERAPY FOR RENAL-CELL CARCINOMA/
Annals of oncology
ALTERED FRACTIONATION OF HEMITHORAX IRRADIATION FOR PLEURAL MESOTHELIOMA AND FAILURE PATTERNS AFTER TREATMENT
Acta oncologica
BRCA-1 SEQUENCE-ANALYSIS IN WOMEN AT HIGH-RISK FOR SUSCEPTIBILITY MUTATIONS - RISK FACTOR-ANALYSIS AND IMPLICATIONS FOR GENETIC TESTING
JAMA, the journal of the American Medical Association
INCREASED THYMIDYLATE SYNTHASE GENE-EXPRESSION IN METASTATIC MELANOMA
Oncology
VASCULARITY AND PROGNOSIS OF METASTATIC MELANOMA
International journal of cancer
VERRUCOUS CARCINOMA OF THE PENIS - 3 CASES TREATED WITH INTERFERON-ALPHA
British Journal of Urology
BREAST-CANCER RISK-ESTIMATION IN FAMILIES WITH HISTORY OF BREAST-CANCER
British Journal of Cancer
COMPARISON OF TOREMIFENE AND TAMOXIFEN IN POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST-CANCER - A RANDOMIZED DOUBLE-BLIND, THE NORDIC PHASE-III STUDY
British Journal of Cancer
SOMATIC GENETIC AND PHENOTYPIC CHARACTERISTICS OF HEREDITARY BREAST-CANCER
American journal of human genetics
A LAW PROPORTION OF BRCA1 AND BRCA2 MUTATIONS IN FINNISH BREAST-CANCER FAMILIES - STRONG EVIDENCE FOR ADDITIONAL SUSCEPTIBILITY GENES
American journal of human genetics
A LOW PROPORTION OF BRCA2 MUTATIONS IN FINNISH BREAST-CANCER FAMILIES
American journal of human genetics
CHEMOSENSITIVITY OF HUMAN-MELANOMA METASTASES IN MOUSE SUBRENAL CAPSULE ASSAY - CAN IT PREDICT TUMOR RESPONSE TO COMBINED CYTOSTATIC PLUS INTERFERON THERAPY IN METASTATIC MELANOMA
Melanoma research
A PHASE-II TRIAL OF DOCETAXEL IN ADVANCED NONSMALL CELL LUNG-CANCER
Anti-cancer drugs
CYTOKINE THERAPY OF MALIGNANT-MELANOMA
Annals of medicine
ANTIESTROGENS AND THE REDUCTION IN CIRCULATING CHOLESTEROL - IN REPLY
Journal of clinical oncology
THE CD4+ CD8+ RATIO AS A PROGNOSTIC FACTOR IN PATIENTS WITH METASTATIC MELANOMA RECEIVING CHEMOIMMUNOTHERAPY/
Journal of clinical oncology
THE EFFECT OF ANTIESTROGENS ON CYTOKINE PRODUCTION IN-VITRO
Scandinavian journal of immunology
RADIOSENSITIVITY OF MESOTHELIOMA CELL-LINES
Acta oncologica
A COMBINATION OF VINBLASTINE AND DOXORUBICIN WITH INTERFERON-ALPHA
American journal of clinical oncology
PROPHYLACTIC FILGRASTIM (G-CSF) DURING MITOMYCIN-C, MITOXANTRONE, ANDMETHOTREXATE (MMT) TREATMENT FOR METASTATIC BREAST-CANCER - A RANDOMIZED STUDY
American journal of clinical oncology
RADIATION-THERAPY OF INTRACRANIAL MALIGNANT-MELANOMA
Radiotherapy and oncology
EFFECT OF ANTIESTROGEN REGIMEN ON PROSTACYCLIN AND THROMBOXANE A(2) IN POSTMENOPAUSAL PATIENTS WITH BREAST-CANCER - EVIDENCE OF SIGNIFICANCE OF HYPERTENSION, SMOKING OR PREVIOUS USE OF ESTROGEN THERAPY
Prostaglandins
EFFECT OF IV-INFUSION ON SALIVARY FLOW IN LYMPHOMA PATIENTS
Journal of dental research
CHEMOTHERAPY IN NON-SMALL-CELL LUNG-CANCER - A METAANALYSIS USING UPDATED DATA ON INDIVIDUAL PATIENTS FROM 52 RANDOMIZED CLINICAL-TRIALS
BMJ. British medical journal
TAMOXIFEN AND TOREMIFENE - THE BENEFICIAL HYPOLIPEMIC EFFECT IN WOMENIS MEDIATED BY CHOLESTEROL-BIOSYNTHESIS INHIBITION
European journal of cancer
INCREASED THYMIDYLATE SYNTHASE GENE-EXPRESSION IN METASTATIC MELANOMA
European journal of cancer
PHASE-III RANDOMIZED STUDY OF 2 FLUOROURACIL COMBINATIONS WITH EITHERINTERFERON-ALFA-2A OR LEUCOVORIN FOR ADVANCED COLORECTAL-CANCER
Journal of clinical oncology
TAMOXIFEN AND TOREMIFENE LOWER SERUM-CHOLESTEROL BY INHIBITION OF DELTA(8)-CHOLESTENOL CONVERSION TO LATHOSTEROL IN WOMEN WITH BREAST-CANCER
Journal of clinical oncology
RISK OF 2ND CANCERS AMONG LUNG-CANCER PATIENTS
Acta oncologica
RESPONSE OF SUBCUTANEOUS AND CUTANEOUS METASTASES OF MALIGNANT-MELANOMA TO COMBINED CYTOSTATIC PLUS INTERFERON THERAPY
British journal of dermatology
RANDOMIZED COMPARISON OF FLUOROURACIL, EPIDOXORUBICIN AND METHOTREXATE (FEMTX) PLUS SUPPORTIVE CARE WITH SUPPORTIVE CARE ALONE IN PATIENTS WITH NONRESECTABLE GASTRIC-CANCER
British Journal of Cancer
DECREASING CD4 CD8 RATIO DURING PROLONGED 4-DRUG CHEMOTHERAPY PLUS INTERFERON TREATMENT FOR METASTATIC MELANOMA/
Journal of immunotherapy with emphasis on tumor immunology
EFFECT OF ANTICANCER DRUGS ON PATIENTS WITH AND WITHOUT INITIALLY REDUCED SALIVA FLOW
European journal of cancer. Part B, Oral oncology
A COMBINATION OF SUBCUTANEOUS RECOMBINANT INTERLEUKIN-2 AND RECOMBINANT INTERFERON-ALPHA IN THE TREATMENT OF ADVANCED RENAL-CELL CARCINOMA OR MELANOMA
European journal of cancer
SUBSEQUENT PRIMARY CANCERS FOLLOWING BLADDER-CANCER
European journal of cancer
PHASE-II STUDY OF VINBLASTINE AND DOXORUBICIN IN ADVANCED RENAL-CELL CARCINOMA
European journal of cancer
SALVAGE THERAPIES IN WOMEN WHO FAIL TO RESPOND TO FIRST-LINE TREATMENT WITH FLUOROURACIL, EPIRUBICIN, AND CYCLOPHOSPHAMIDE FOR ADVANCED BREAST-CANCER
Journal of clinical oncology
MOUSE SUBRENAL CAPSULE ASSAY CHEMOSENSITIVITY AND DNA FLOW-CYTOMETRY PARAMETERS OF HUMAN-MELANOMA METASTASES
Acta oncologica
EPIRUBICIN-SEQUENTIAL METHOTREXATE-5-FLUOROURACIL-LEUCOVORIN TREATMENT IN ADVANCED CANCER OF THE EXTRAHEPATIC BILIARY SYSTEM - A PHASE-II STUDY
American journal of clinical oncology
HIGH-DOSE TOREMIFENE IN ADVANCED BREAST-CANCER RESISTANT TO OR RELAPSED DURING TAMOXIFEN TREATMENT
Breast cancer research and treatment
PACLITAXEL-INDUCED MYOCARDIAL DAMAGE DETECTED BY ELECTRON-MICROSCOPY
Lancet
ENHANCED EXPRESSION OF THE TIE RECEPTOR TYROSINE KINASE MESSENGER-RNAIN THE VASCULAR ENDOTHELIUM OF METASTATIC MELANOMAS
Cancer research
EVIDENCE FOR INVOLVEMENT OF BRCA1 IN SPORADIC BREAST CARCINOMAS
Cancer research
POOR-PROGNOSIS ASSOCIATED WITH ELEVATED SERUM CA 19-9 LEVEL IN ADVANCED COLORECTAL-CARCINOMA, INDEPENDENT OF DNA-PLOIDY OR SPF
European journal of cancer
ONE-YEAR TRIAL OF THE EFFECT OF RINSING WITH AN AMINE FLUORIDE-STANNOUS-FLUORIDE-CONTAINING MOUTHWASH ON GINGIVAL INDEX SCORES AND SALIVARYMICROBIAL COUNTS IN LYMPHOMA PATIENTS RECEIVING CYTOSTATIC DRUGS
Journal of clinical periodontology
RADIOIMMUNODETECTION AND RADIOIMMUNOTHERAPY OF MALIGNANT-MELANOMA - AREVIEW
Acta oncologica
AMPLIFICATION OF FGFR4 GENE IN HUMAN BREAST AND GYNECOLOGICAL CANCERS
International journal of cancer
CHEMOTHERAPY PLUS ALPHA-INTERFERON IN THE TREATMENT OF SMALL-CELL LUNG-CANCER - A RANDOMIZED PHASE-III STUDY
The American review of respiratory disease